Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
New words:
accrual, alteration, answer, attained, bankruptcy, bioitec, biolitiec, Bioniche, brand, California, cardiothoracic, cardiovascular, clinical, comply, composition, concentration, conversion, counterclaim, cured, device, director, disagreed, disagreement, distributor, distributorship, enterprise, EVLT, faith, field, firm, Food, good, grace, ingredient, injury, insecure, insolvency, instructing, Intangible, jury, labeling, leader, MMC, modification, motion, moved, Northern, notice, outcome, packaging, person, Pharma, pharmaceutical, polidocanol, presence, refinement, registered, relationship, relief, remedy, remove, repay, request, resolve, resource, response, responsible, revolving, sclerosing, sclerotherapy, sodium, Sotradecol, SotradecolTM, strategy, streamline, strength, sulfate, summary, Territory, tetradecyl, trial, ultimately, unaffiliated, unauthorized, unfavorable, written
Filing tables
Filing exhibits
Related press release
ANGO similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO TITLE 18,
UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Joseph G. Gerardi, Vice President - Chief Financial Officer of AngioDynamics, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
1. | the Quarterly Report on Form 10-Q of the Company for the quarter ended August 27, 2005 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date January 10, 2006 | /s/ Joseph G. Gerardi | |
Joseph G. Gerardi, Vice President - Chief Financial Officer |